We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$40.1B
AUM Growth
-$4.93B
(-11%)
Cap. Flow
-$4.88B
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
19.14%
Holding
959
New
32
Increased
238
Reduced
614
Closed
39
Avg Time Held
1.7
years
Top 10 Avg Time Held
1.3
years
Top 20 Avg Time Held
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$192M |
| 2 |
Fiserv Inc
FISV
|
+$93.4M |
| 3 |
American Express
AXP
|
+$91.1M |
| 4 |
Prologis
PLD
|
+$86.5M |
| 5 |
AbbVie
ABBV
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$197M |
| 3 |
Apple
AAPL
|
+$164M |
| 4 |
RTN
Raytheon Company
RTN
|
+$154M |
| 5 |
Chevron
CVX
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 15.72% |
| 3 | Consumer Discretionary | 12.22% |
| 4 | Healthcare | 10.98% |
| 5 | Communication Services | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
251
Allstate
ALL
$61.8B
| $28.2M | 0.07% |
259,203
-123,921
| -32% | -$12.9M |
2017 Q3
8 quarters
|
|
252
Delta Air Lines
DAL
$51.3B
| $27.9M | 0.07% |
484,508
-110,579
| -19% | -$6.55M |
2017 Q3
8 quarters
|
|
253
ResMed
RMD
$33.8B
| $27.9M | 0.07% |
206,359
-22,869
| -10% | -$3M |
2017 Q3
8 quarters
|
|
254
DELISTED
Cubic Corporation
CUB
| $27.9M | 0.07% |
+396,055
| New | +$27.1M |
2019 Q3
0 quarters
|
|
255
Kroger
KR
$37.4B
| $27.7M | 0.07% |
1,074,383
-581,671
| -35% | -$13.5M |
2017 Q3
8 quarters
|
|
256
Morgan Stanley
MS
$287B
| $27.5M | 0.07% |
644,503
-60,039
| -9% | -$2.57M |
2017 Q3
8 quarters
|
|
257
TE Connectivity
TEL
$61.9B
| $27.4M | 0.07% |
294,073
-30,245
| -9% | -$2.78M |
2017 Q3
8 quarters
|
|
258
DuPont de Nemours
DD
$17.9B
| $27.2M | 0.07% |
303,902
-116,773
| -28% | -$10.3M |
2017 Q3
8 quarters
|
|
259
Travelers Companies
TRV
$81B
| $27.2M | 0.07% |
182,538
-6,493
| -3% | -$965K |
2017 Q3
8 quarters
|
|
260
Marathon Petroleum
MPC
$134B
| $27M | 0.07% |
443,813
-189,945
| -30% | -$10M |
2017 Q3
8 quarters
|
|
261
WSFS Financial
WSFS
$3.92B
| $26.6M | 0.07% |
603,495
-208,297
| -26% | -$8.76M |
2017 Q3
8 quarters
|
|
|
CCMP
262
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $26.6M | 0.07% |
188,408
-93,520
| -33% | -$11.5M |
2017 Q4
7 quarters
|
|
|
STOR
263
DELISTED
STORE Capital Corporation
STOR
| $26.5M | 0.07% |
708,585
+223,623
| +46% | +$8.01M |
2018 Q2
5 quarters
|
|
264
Cigna
CI
$79.9B
| $26.4M | 0.07% |
173,935
-5,763
| -3% | -$938K |
2019 Q1
2 quarters
|
|
265
Emergent Biosolutions
EBS
$327M
| $26.4M | 0.07% |
504,843
-205,408
| -29% | -$9.57M |
2017 Q3
8 quarters
|
|
266
Regions Financial
RF
$23.6B
| $26.4M | 0.07% |
1,666,766
-736,292
| -31% | -$11.1M |
2017 Q3
8 quarters
|
|
267
CSX Corp
CSX
$90.3B
| $26.4M | 0.07% |
1,141,506
-2,282,832
| -67% | -$53.1M |
2017 Q3
8 quarters
|
|
|
MGP
268
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $26.3M | 0.07% |
875,890
+548,431
| +167% | +$16.5M |
2019 Q1
2 quarters
|
|
269
Ambev
ABEV
$50.4B
| $26.3M | 0.07% |
5,685,169
-1,729,800
| -23% | -$8.28M |
2017 Q3
8 quarters
|
|
270
Kimberly-Clark
KMB
$35B
| $26.1M | 0.07% |
183,679
-4,630
| -2% | -$636K |
2017 Q3
8 quarters
|
|
271
First Interstate BancSystem
FIBK
$3.35B
| $25.9M | 0.06% |
644,129
+27,298
| +4% | +$1.07M |
2019 Q1
2 quarters
|
|
272
Hudson Pacific Properties
HPP
$606M
| $25.8M | 0.06% |
110,091
+35,777
| +48% | +$8.53M |
2017 Q3
8 quarters
|
|
273
Sysco
SYY
$40.7B
| $25.6M | 0.06% |
322,816
-115,989
| -26% | -$8.51M |
2017 Q3
8 quarters
|
|
274
Dorman Products
DORM
$3.68B
| $25.4M | 0.06% |
319,653
+19,511
| +7% | +$1.51M |
2019 Q1
2 quarters
|
|
275
Mercury Systems
MRCY
$4.46B
| $25.1M | 0.06% |
309,654
-56,604
| -15% | -$4.47M |
2019 Q1
2 quarters
|
|
Similar funds
Aberdeen Group's Q3 2019 Portfolio in Review
As of Q3 2019, Aberdeen Group held 959 positions worth $40.1B, down 11% from $45B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aberdeen Group withdrew a net $4.88B in Q3 2019, closing 39 positions and reducing 614 holdings. Its most notable exit was L3Harris, an estimated $88.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $40.7M.
- Aberdeen Group's largest Q3 2019 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,493,397 shares worth $40.7M.
- Aberdeen Group added most to Fidelity National Information Services in Q3 2019, an estimated $192M increase.
- Aberdeen Group's biggest Q3 2019 reduction was Wells Fargo, cutting an estimated $206M.
- Aberdeen Group fully exited L3Harris in Q3 2019, selling an estimated $88.4M.
- Aberdeen Group's ten largest holdings make up 19% of its $40.1B portfolio in Q3 2019.
- Aberdeen Group opened 32 new positions and closed 39 in Q3 2019.
- Aberdeen Group's portfolio value fell 11% quarter-over-quarter to $40.1B.
Based on Aberdeen Group's 13F filing for Q3 2019, filed 13 Nov 2019.